Cargando…
Oseltamivir Prescription and Regulatory Actions Vis-à-Vis Abnormal Behavior Risk in Japan: Drug Utilization Study Using a Nationwide Pharmacy Database
BACKGROUND: In March 2007, a regulatory advisory was issued in Japan to restrict oseltamivir use in children aged 10-19 years because of safety concerns over abnormal behavior. The effectiveness and validity of regulatory risk minimization actions remain to be reviewed, despite their significant pub...
Autores principales: | Urushihara, Hisashi, Doi, Yuko, Arai, Masaru, Matsunaga, Toshiyuki, Fujii, Yosuke, Iino, Naoko, Kawamura, Takashi, Kawakami, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232227/ https://www.ncbi.nlm.nih.gov/pubmed/22163021 http://dx.doi.org/10.1371/journal.pone.0028483 |
Ejemplares similares
-
Prescription Patterns of Medications for Alzheimer’s Disease in Japan from 2010 to 2015: A Descriptive Pharmacy Claims Database Study
por: Kadohara, Kimiko, et al.
Publicado: (2016) -
The Pathogenesis of Adenomyosis vis-à-vis Endometriosis
por: Guo, Sun-Wei
Publicado: (2020) -
Citicoline and COVID-19: vis-à-vis conjectured
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
Vis Conservatrix
por: Payne, F. R.
Publicado: (1867) -
PHARMACEUTICAL PROCESSING IN PANCHAKARMA VIS –A-VIS POLIO MYELITIS
por: Chaube, Anjana, et al.
Publicado: (1996)